01 1Chongqing Carelife Pharmaceutical
01 1REGORAFENIB
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2023-08-14
Pay. Date : 2023-05-08
DMF Number : 38197
Submission : 2023-04-26
Status : Active
Type : II
20
Chongqing Carelife Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is REGORAFENIB, with a corresponding US DMF Number 38197.
Remarkably, this DMF maintains an Active status since its submission on April 26, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 14, 2023, and payment made on May 08, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II
